Semotiuk S S, Khalaĭm Ie A
Fiziol Zh (1994). 1994 Mar-Apr;40(2):43-5.
Results presented in this paper confirm that the drug ersol (VAP-1) created by the authors on the basis of ultraviolet irradiated blood preserves its immunostimulating effects on the phagocytic activity of UV-irradiated blood. Experiments in vitro and in vivo show that the drug increases the number of leukocytes in the blood and activates nonspecific resistance factors. The results obtained permit VAP-1 to be recommended for further study with the aim to determine its applicability in medicine and veterinary as a treatment-and-prophyctic remedy.
本文所呈现的结果证实，作者基于紫外线照射血液研制的药物厄索尔（VAP - 1）对紫外线照射血液的吞噬活性保持其免疫刺激作用。体外和体内实验表明，该药物可增加血液中白细胞数量并激活非特异性抵抗因子。所得结果允许推荐对VAP - 1进行进一步研究，目的是确定其在医学和兽医学中作为治疗和预防药物的适用性。
